<i>Retracted</i> : Combined therapy using LHRH‐PE40 and anti‐CD40 dendritic cells substantially eliminate tumor cells

Limin Zhang, TianJiao Du, DongBin Ma, Fang Guo, ZhenWei Li, Hua Yan

Open source

DOI
10.1002/jcb.28088
Published
2018-11-28
Container
Journal of Cellular Biochemistry
Publisher
Wiley
Open access
unknown

Credibility signals

serious concern Score 29/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1002/jcb.28088,
  title = {<i>Retracted</i>
                    : Combined therapy using LHRH‐PE40 and anti‐CD40 dendritic cells substantially eliminate tumor cells},
  author = {Limin Zhang and TianJiao Du and DongBin Ma and Fang Guo and ZhenWei Li and Hua Yan},
  year = {2018},
  journal = {Journal of Cellular Biochemistry},
  doi = {10.1002/jcb.28088},
  url = {https://doi.org/10.1002/jcb.28088}
}

RIS

TY  - JOUR
TI  - <i>Retracted</i>
                    : Combined therapy using LHRH‐PE40 and anti‐CD40 dendritic cells substantially eliminate tumor cells
AU  - Limin Zhang
AU  - TianJiao Du
AU  - DongBin Ma
AU  - Fang Guo
AU  - ZhenWei Li
AU  - Hua Yan
PY  - 2018
JO  - Journal of Cellular Biochemistry
DO  - 10.1002/jcb.28088
UR  - https://doi.org/10.1002/jcb.28088
ER  - 

APA

Zhang, L., Du, T., Ma, D., Guo, F., Li, Z., & Yan, H. (2018). <i>Retracted</i> : Combined therapy using LHRH‐PE40 and anti‐CD40 dendritic cells substantially eliminate tumor cells. Journal of Cellular Biochemistry. https://doi.org/10.1002/jcb.28088

Source records